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Parkinsonian toxin-induced oxidative stress
inhibits basal autophagy in astrocytes via
NQO2/quinone oxidoreductase 2: Implications
for neuroprotection
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CA-DCF-DA, 5(6)-carboxy-20,70 dichlorofluorescein diacetate; DMEM, Dulbecco’s modified Eagle’s medium; DMSO, dimethyl
sulfoxide; FACS, flow cytometry; GFAP, glial fibrillary acidic protein; GFP, green fluorescent protein; K3, menadione; MAPK,
mitogen-activated protein kinase; MFI, mean fluorescence intensity; MitoSOX, 3,8-phenanthridinediamine, 5-(60-triphenylphospho-
niumhexyl)-5,6 dihydro-6-phenyl; MPTP, 1-methyl 4-phenyl 1,2,3,6-tetraidro-piridine; NMDPEF, N-[2-(2-methoxy-6H-dipyrido
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Oxidative stress (OS) stimulates autophagy in different cellular systems, but it remains controversial if this rule can be
generalized. We have analyzed the effect of chronic OS induced by the parkinsonian toxin paraquat (PQ) on autophagy
in astrocytoma cells and primary astrocytes, which represent the ﬁrst cellular target of neurotoxins in the brain. PQ
decreased the basal levels of LC3-II and LC3-positive vesicles, and its colocalization with lysosomal markers, both in the
absence and presence of chloroquine. This was paralleled by increased number and size of SQSTM1/p62 aggregates.
Downregulation of autophagy was also observed in cells chronically exposed to hydrogen peroxide or nonlethal
concentrations of PQ, and it was associated with a reduced astrocyte capability to protect dopaminergic cells from OS
in co-cultures. Surprisingly, PQ treatment led to inhibition of MTOR, activation of MAPK8/JNK1 and MAPK1/ERK2-
MAPK3/ERK1 and upregulation of BECN1/Beclin 1 expression, all signals typically correlating with induction of
autophagy. Reduction of OS by NMDPEF, a speciﬁc NQO2 inhibitor, but not by N-acetylcysteine, abrogated the
inhibitory effect of PQ and restored autophagic ﬂux. Activation of NQO2 by PQ or menadione and genetic manipulation
of its expression conﬁrmed the role of this enzyme in the inhibitory action of PQ on autophagy. PQ did not induce
NFE2L2/NRF2, but when it was co-administered with NMDPEF NFE2L2 activity was enhanced in a SQSTM1-independent
fashion. Thus, a prolonged OS in astrocytes inhibits LC3 lipidation and impairs autophagosome formation and
autophagic ﬂux, in spite of concomitant activation of several pro-autophagic signals. These ﬁndings outline an
unanticipated neuroprotective role of astrocyte autophagy and identify in NQO2 a novel pharmacological target for its
positive modulation.
Introduction
Parkinson disease (PD) is a common neurodegenerative disor-
der that is primarily characterized by progressive loss of
dopaminergic neurons in substantia nigra (SN) pars compacta
and consequent reduced dopamine production. The glial cells
(astrocytes and microglia) play a complex role in dopaminergic
neurotoxicity.1-5 Both microglia and astrocytes can degrade
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dopamine with consequent generation of oxidative stress (OS)
and detrimental effects on dopaminergic neurons.6,7 While par-
kinsonian neurotoxins activate microglial cells5 leading to neuro-
inflammation in nigrostriatal area, the protective effects of
astrocytes in development and regeneration of the nigrostriatal
dopamine system largely outweigh the pro-inflammatory role of
the glia.3,8,9 Astrocytes contribute to the blood-brain barrier8 and
protect neurons from OS induced by hydrogen peroxide
(H2O2), toxic metabolites and neurotransmitters, including
dopamine, 6-hydroxydopamine, and glutamate.10-12 This prop-
erty has been associated with a basally high expression of
NFE2L2 (nuclear factor, erythroid 2-like 2) that leads to
increased synthesis and secretion of glutathione.13
Autophagy, a lysosome-dependent degradation pathway of
self-constituents, normally runs at low basal level to ensure cell
homeostasis and is activated in response to starvation and meta-
bolic stress to prevent accumulation of damaged organelles and
protein aggregates.14-16 Defects in the autophagy machinery have
been implicated in several neurodegenerative disorders, including
PD.17,18 The progressive accumulation of protein inclusions con-
taining SQSTM1/p62, ubiquitin and/or SNCA/a-synuclein in
PD,19-21 Lewy bodies disease, and related disorders21-23 is
observed not only in neurons, but also in astrocytes, suggesting
that defective autophagy is common to both cell subsets present
in affected areas of the brain. The vast majority of studies that
address dysregulation of autophagy by toxins mimicking PD are
limited to dopaminergic cell lines and primary neurons as cellular
models of PD.24,25 However, under physiological conditions,
when the blood-brain barrier functions correctly, dopaminergic
neurons of the SN are not directly exposed to parkinsonian tox-
ins, which are instead absorbed and metabolized by astrocytes.6,8
In fact, astrocytes are the first target of neurotoxins and thanks to
their powerful antioxidant machinery they represent the first line
of brain defense against such toxins.13,26-28
Parkinsonian toxins applied to rodents or primates reproduce
only certain features of PD.25,29 Among them, SNCA accumula-
tion and Lewy bodies-like protein inclusions are effectively
induced only by PQ30 and rotenone.31 All parkinsonian toxins
generate reactive oxygen species (ROS) and/or reactive nitrogen
species by disruption of the mitochondrial electron transport
chain and/or production of toxic metabolites leading to altered
energy metabolism.32 In addition, PQ-induced cellular toxicity
depends on the presence of oxidoreductases able to reduce PQ by
one electron transfer,33 such as plasma membrane NOX 1
(NADPH oxidase 1)34 or mitochondrial COX/ubiquinol: cyto-
chrome c oxidase.35 We have recently identified a cytoplasmic
flavoenzyme, NQO2/quinone oxidoreductase 2 (NAD[P]H
dehydrogenase, quinone 2), as another critical mediator of PQ-
induced OS and toxicity.36 Silencing of NQO2 conferred a par-
tial or full protection in astroglial cells exposed to intermediate
concentrations of PQ, and inhibition of NQO2 activity by its
specific inhibitor prevented PQ-induced OS, cell death in vitro
and animal mortality in models of acute PQ-induced systemic-
and SN-toxicity.36 These findings provided further evidence that
NQO2 may play a toxifying role in biological systems in the
presence of certain xenobiotics.37
ROS generated by H2O2 or MPP
C (the active MPTP metab-
olite) induce a strong autophagic response in dopaminergic cell
lines,38,39 and primary cortical and nigrostriatal neurons,40,41
leading to the activation of a cell death program. Nevertheless, it
is unclear if the rule “OS causes autophagy” can be applied to all
cell systems and different types of OS. Indeed, several lines of evi-
dence suggest that OS may also have a negative impact on the
autophagy machinery, as recently reviewed by us.17,25
Here, we demonstrate that chronic exposure to pro-oxidants,
such as PQ and H2O2, reduces basal autophagy in astrocytes.
This effect is dose-dependent and occurs also at nonlethal con-
centrations of PQ. Coculture experiments showed that the
impairment of autophagy limited the capacity of astrocytes to
protect dopaminergic neuroblastoma cells from a lethal OS.
Intriguingly, in spite of a marked decrease in LC3 lipidation, PQ
induced a series of proautophagic signals including BECN1 upre-
gulation, and MAPK8 and MAPK1/3 activation. Furthermore,
we identify NQO2 as a mediator of the negative effects of PQ on
autophagy. Thus, PQ-induced OS generates both positive and
negative signals affecting the autophagy machinery and antioxi-
dant capacity of astrocytes, and the balance between these signals
can be modulated pharmacologically by NQO2 inhibition. The
present findings have important pathophysiological implications:
first, they uncover a neuroprotective role of autophagy in astro-
cytes that outlines the active involvement of these cells in the
pathogenesis of OS-related neurodegenerative diseases; second,
the fact that inhibition of NQO2 activity can restore protective
autophagy in OS astrocytes could be clinically exploited for the
treatment of OS-associated neurodegeneration.
Results
Paraquat negatively affects basal autophagy in astrocytoma
cells
We previously reported that astrocytoma U373 cells exposed
to PQ-induced OS undergo a delayed, nonapoptotic cell death.36
Whether autophagy was involved in either promoting or counter-
acting this phenomenon remained to be elucidated. The western
blotting analysis of U373 cell lysates revealed a time- and dose-
dependent decrease of lipidated LC3 (LC3-II), a fundamental
component of phagophore and autophagosomal membranes
(Fig. 1A and B). Next, we analyzed the levels of SQSTM1, a
ubiquitin-binding protein that functions as a receptor for auto-
phagic substrates42,43 and is an abundant component of protein
inclusions associated with neurodegenerative disorders.21-23
SQSTM1 levels were dose-dependently increased 24 h post-
treatment (Fig. 1C and D), suggesting a reduced formation or
turnover of autophagosomes. The lack of significant increase in
SQSTM1 levels at 48 h was possibly due to SQSTM1 precipita-
tion into insoluble aggregates, considering the presence of high
amounts of SQSTM1 in the cell lysate fraction insoluble to 1%
Igepal (Fig. 1C). The above observations were confirmed by
immunofluorescence staining for autophagic structures
(Fig. 2A). PQ (100 mM, 24 h) caused a more than 3–fold
decrease in LC3-positive autophagic vacuoles (AVs) (Fig. 2B)
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and a strong reduction in AV-positive cells (Fig. 2C) compared
to untreated cells. This was accompanied by a mild increase in
the number of SQSTM1 granules (Fig. 2A and D) and a strong
increase in the SQSTM1 staining intensity (Fig. 2A and E). In
addition, PQ strongly impaired the colocalization of SQSTM1
and LC3 (Fig. 2A and F), suggesting that many SQSTM1-tar-
geted aggregates were not engulfed within autophagosomes.
Paraquat inhibits the formation of autophagosomes
Autophagy is a dynamic process and an apparent LC3-II
downregulation may be due to scarce production or prompt con-
sumption of autophagosomes.44 The treatment with drugs that
abrogate vacuolar acidification, such as chloroquine (CQ), helps
to discriminate between these 2 possibilities. To determine if the
decrease of LC3 dots was the result of reduced formation or of
accelerated consumption of autophagosomes, we added CQ to
U373 cells during the last 4 h of PQ treatment (Fig. 3A). In cul-
tures not exposed to PQ, CQ greatly increased the number of
LC3-positive vesicles, while in PQ-treated cells this increase was
modest (Fig. 3A and B). Accordingly, the levels of LC3-II pro-
tein in cells treated with 10 or 100 mM PQ along with CQ were
lower than in CQ-only treated cells (Fig. 3C). We further con-
firmed that any treatment with CQ, ranging from 1 up to 18 h
before cell lysis, resulted in a lower LC3-II accumulation in PQ-
treated cells than in control cells (Figs. 4–8 and data not shown).
The inhibitory effect of PQ was not limited to basal autoph-
agy. In fact, the herbicide also inhibited rapamycin-induced
autophagy in U373 cells, as the induction of LC3-II levels by
rapamycin was potently blocked by PQ, both in the presence and
absence of CQ (Fig. 3D). These data consistently demonstrate
that in this cell system PQ blocks autophagy before or at the step
of autophagosome formation.
Inhibition of autophagy limits the anti-oxidant and
neuroprotective capabilities of astrocytes
Chronic exposure to very low concentrations of PQ likely con-
tributes to PD pathogenesis.45,46 To mimic this condition in vitro,
we chronically applied nonlethal concentrations of PQ for several
days. 1 mM PQ is not lethal for at least 9 d to U373 astrocytes, if
cells are maintained in daily-changed culture medium containing
4.5% glucose (data not shown). 1 mM PQ applied for 7 d (long
term, LT-PQ) led to a significant decrease in LC3-II, more evident
in the presence of CQ, and caused a concomitant SQSTM1 accu-
mulation (Fig. 4A and B) and aggregation (Fig. 4C). Next, we
asked if the impairment of autophagy in astrocytes could affect their
viability and antioxidant capacity. After 24-h exposure to H2O2,
LT-PQ cultures contained significantly less viable cells than control
U373 cultures, yet LT-PQ U373 cells were more resistant to H2O2
than dopaminergic neuroblastoma SH-SY5Y cells (Fig. 4D). We
have previously reported that SH-SY5Y cells subjected to similar
concentrations of H2O2 rapidly activate autophagy and eventually
undergo autophagy-dependent cell death.38,39 The important role
of astrocytes, among others, is to protect dopaminergic neurons
from oxidative insults.10,13 This antioxidant capacity of astrocytes
can be assessed in vitro in coculture with neuronal cells.15We estab-
lished mixed cell cultures and found that dopaminergic neuroblas-
toma SH-SY5Y cells were significantly protected from H2O2 if
cultured in the presence of control U373 cells, but not if cocultured
with LT-PQ U373 (Fig. 4E and F). In the latter case, a decreased
ratio of viable GFAP-negative cells (SH-SY5Y) compared to
GFAP-positive U373 cells was observed (Fig. 4E and F). These
data indicate that a chronic exposure to low concentration of PQ
negatively affects autophagy and concomitantly diminishes the anti-
oxidant and neuroprotective capacities of astrocytes.
Downregulation of LC3-II is a response to chronic, but not
transient, OS in astrocytes
Astrocytes are highly resistant to OS.36,47 The lack of auto-
phagic response to H2O2 in primary mouse astrocytes has been
previously attributed to no ROS generation.48,49 To exclude
Figure 1. Paraquat-induced changes in LC3-II and SQSTM1 levels sug-
gest time- and dosage-dependent inhibition of basal autophagy. (A)
Time- and concentration-dependent decrease in LC3-II levels in response
to PQ. U373 cells were treated with 3 different concentrations of PQ for
the indicated times before lysis. LC3-II was analyzed by 15% SDS-PAGE
and WB. (B) The experiment was repeated from n D 3 to 7 times as indi-
cated. Bars represent the mean of LC3-II optical density (OD) C/¡ SEM
normalized to vehicle-treated controls, which were set to 1. Statistical
analysis was performed by ANOVA followed by Dunnett’s post-test; 3 – 9
OD values for each group, 4 groups; *P < 0.05, **P < 0.01. (C) Time- and
dosage-dependent accumulation of SQSTM1 in soluble and detergent-
resistant fractions. The samples from the experiments described in (A)
and the corresponding Igepal 1% insoluble fraction of lysates were
loaded on 8% SDS-PAGE gels and analyzed for SQSTM1 expression by
WB. (D) Densitometric and subsequent statistical analysis were per-
formed as described in (A) for n experiments. TUBA/a-tubulin or pon-
ceau staining used as loading controls, were used for OD normalization.
Four–8 OD values for each group, 4 groups, *P < 0.05, **P < 0.01.
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such a possibility in U373 cells, we measured ROS levels in
response to the herbicide and H2O2 by using the fluorescent
probes CA-DCF-DA and MitoSox, which preferentially detect
hydroxylradical (OH) and mitochondrial and cytoplasmic
superoxide (O2
¡), respectively.39 PQ turned out to be a poor
inducer of OH compared to H2O2 (Fig. 5A), but both PQ and
H2O2 caused a significant increase of O2
¡, although the kinetics
and the extent of its induction were different for PQ and H2O2
(Fig. 5B). In addition, the rapid induction of O2
¡ in U373 cells
by H2O2 temporally correlated with a dose-dependent decrease
of LC3-II levels at 4 h and 24 h post-treatment, in the presence
or absence of CQ (Fig. 5C and D). H2O2 also induced a dose-
dependent formation of insoluble SQSTM1 aggregates (Fig. 5C
and D), which, however, did not accumulate with time as cell
death rapidly occurred (data not shown).
We further addressed if the negative effect of PQ and H2O2
on basal autophagy in U373 cells was an unusual feature of this
cell line or a common response to prolonged OS in astrocytes.
Primary mouse astrocytes were expanded for 10 d after isolation
before exposing the cells to OS. 100 mM PQ and 1 mM H2O2
applied for 16 h had little effect on LC3 lipidation, but a longer
exposure (48 h) to pro-oxidants led to a significant decrease in
LC3-II levels (Fig. 5E) and in LC3 dots (Fig. 5F). This effect
occurred days before any signs of cell death, as primary astrocytes
showed very low mortality until d 4 and
d 3 post-treatment in response to
100 mM PQ (Fig. 7H) and 1 mM
H2O2 (data not shown), respectively. In
addition, primary astrocytes exposed for
7 d to a low concentration of PQ
(3 mM) also accumulated SQSTM1
aggregates in contrast to astrocytes cul-
tured under the same conditions, but
without PQ (Fig. 5G).
PQ triggers upstream
pro-autophagic signals
To find the mechanism underlying
the PQ-induced block of basal autophagy
we measured the levels of BECN1 upon
PQ treatment, as downregulation of this
protein inhibits basal and starvation-
induced autophagy.50 Unexpectedly, we
found a dose-dependent induction of
BECN1 in cells exposed to different con-
centrations of PQ (Fig. 6A). Interest-
ingly, BECN1 accumulated in the
insoluble fraction of lysates at the 48 h
time point (Fig. 6B), suggesting that it
was part of a membrane-associated oligo-
meric complex. This interpretation was
supported by immunofluorescence stain-
ing for BECN1, which showed increased
intensity and colocalized with PIK3C3/
VPS34 upon 16 h treatment with PQ
(Fig. 6C).
We investigated other possible signaling pathways regulating
autophagy in response to PQ. MTOR activation leads to autoph-
agy suppression in the majority of cell systems.17 However,
100 mM PQ did not induce significant activation of MTOR at
early time points, whereas it strongly inhibited MTOR after
24 h (Fig. 6D), when autophagy was clearly suppressed in our
system. Accordingly, RPS6KB/p70S6 kinase phosphorylation,
which reflects MTOR activity, was inhibited or unchanged up to
6 h after PQ treatment and strongly suppressed after 24 h
(Fig. 6E). These data suggest that the negative regulation of
autophagy by PQ does not involve MTOR. Starvation-induced
autophagy and MPPC-induced autophagy are mediated by the
activation of MAPK8/JNK1 (mitogen-activated protein kinase
8).50,51 Similarly, a transient increase in MAPK1/ERK2-
MAPK3/ERK1 activity correlates with autophagy induction and
is required for MPPC-50 and zVAD-induced autophagic cell
death.52 PQ led to a significant elevation of MAPK8 phosphory-
lation within 1 h, followed by a very slow decrease back to con-
trol levels (Fig. 6F). Phosphorylation of MAPK1/3 was similarly
modulated by PQ-induced stress, but a significant increase in
p-MAPK1/3 was still detectable 24 h post-treatment (Fig. 6G).
Sustained MAPK1/3 activation blocks the maturation of auto-
phagosomes in cancer cell lines exposed to the pesticide Lin-
dane.53 Remarkably, the MEK1 inhibitor UO126 had little
Figure 2. Paraquat reduces the number of autophagic vacuoles and increases the number and size of
SQSTM1 aggregates in astroglial cells. (A) U373 cells growing on coverslips were treated with PBS
(control) or 100 mM PQ for 24 h. Paraformaldehyde-ﬁxed cells were stained for LC3, SQSTM1, and
actin (FITC-phalloidin). Representative confocal images of middle sections from z stacks are shown
(bar: 25 mm). (B-F) Statistical analysis was performed by using unpaired 2-tailed t test (t-test), for n
images per treatment, at least 50 cells per treatment from 3 independent experiments. *P < 0.05, **P
< 0.01., ***P < 0.001. (B) Mean number of LC3 dots per cell C/¡ SEM, n D 12. (C) Percentage of cells
with  5 LC3 dots per cell C/¡ SEM, n D 12. (D) Mean number of SQSTM1 aggregates per cell C/¡
SEM, n D 11. (E) Mean size x intensity of SQSTM1 dots (i.e., Integrated density, IntDensity) per cell
C/¡ SEM, nD 11. (F) Percentage of SQSTM1 dots not costaining with LC3 (SQSTM1-positive/LC3-neg-
ative dots, SQSTM1pos LC3neg) C/¡ SEM, n D 10.
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effect on basal LC3-II levels in control
cells and further reduced LC3-II in PQ-
treated cells (Fig. 6H), although it
strongly decreased MAPK1/3 phosphory-
lation in PQ-treated and control cells
(Fig. 6I). These data indicate that
MAPK1/3 activation is not an inhibitory
signal elicited by PQ.
Inhibition of OS by a NQO2
inhibitor, but not by N-acetylcysteine,
enhances autophagy in U373 cells and
in primary astrocytes exposed to PQ
To examine the causal role of OS in
PQ-induced downregulation of basal
autophagy we used N-acetylcystein
(NAC), a thiol antioxidant, and
NMDPEF (N-[2-(2-methoxy-6H-dipyr-
ido[2,3-a:3,2-e]pyrrolizin-11-yl)ethyl]-2-
furamide), a pharmacological inhibitor of
NQO2 activity and a powerful PQ-spe-
cific antioxidant in U373 cells.36 Accord-
ing to our previous observations,36
10 mM NMDPEF strongly reduced PQ-
induced ROS, as detected by MitoSox
(Fig. 7A). 5 mM NAC showed compara-
ble effects on mitochondrial ROS, but
the effects of the NQO2 inhibitor were
more stable over time compared to NAC
(Fig. 7A). Remarkably, the addition of
NMDPEF to U373 cells for 24 h
potently enhanced LC3-II processing
(Fig. 7B) and increased the number of
AV dots both in PQ-treated and
untreated cells (Fig. 7C and D). In contrast, cotreatment with
NAC did not restore LC3-II levels in PQ-treated astrocytoma
cells, but it dose-dependently decreased LC3-II in control cells
(Fig. 7D). Of note, NMDPEF not only increased the number of
LC3-positive dots, but it restored the normal percentage of LC3-
LAMP1 double-positive autolysosomes, which were markedly
reduced in PQ-treated cells compared to control cells (Fig. 7C
and E), suggesting that NQO2 inhibition stimulates autophagy
flux. This observation was confirmed by acridine orange staining
and flow cytometry used to assess quantitatively acidic vesicles
such as autolysosomes and lysosomes.54 NMDPEF increased,
whereas NAC reduced, the number of acidic vesicles, in control
and PQ-treated cells (Fig. 7F).
The pro-autophagic effect of the NQO2 inhibitor was further
confirmed in primary mouse astrocytes. NMDPEF restored
LC3-II levels in primary cultures treated with PQ (Fig. 7G and
H), which correlated with a significant protective effect of this
agent against PQ-induced cell death (Fig. 7I), in accordance to
what we previously observed in U373 cells.36 Thus, a NQO2-
specific antioxidant, but not a generic inhibitor of PQ-induced
OS, can prevent deleterious effects of PQ on LC3 lipidation and
autolysosome formation.
NQO2 mediates the negative regulation of LC3-lipidation
by PQ
We further investigated the active involvement of NQO2 in
the negative regulation of basal autophagy induced by PQ.
NMDPEF dose-dependently and time-dependently induced
autophagy, as shown by the increase in LC3 lipidation and
BECN1 (Fig. 8A). This effect was not due to inhibition of the
autophagic flux, since the upregulation of LC3-II in the presence
of NMDPEF and CQ was much higher than in vehicle-treated
cells in the presence of CQ (Fig. 7B). NQO2 is well expressed in
primary astrocytes and U373 cells, although very low levels of
NQO2 can be detected in mouse brain total lysates, suggesting
an astrocyte-specific expression of this enzyme (Fig. 8B). Since
NQO2 activity contributes to OS in astrocytes,36 it may play a
role in the negative regulation of autophagy by chronic OS. To
test this hypothesis, we stimulated NQO2 activity in U373 cells
with the NQO2 substrate menadione (K3). Stimulation of
NQO2 activity rapidly inhibited LC3 lipidation at 1 and 6 h,
although at later time points LC3-II accumulated most likely due
to inhibition of the autophagic flux (Fig. 8C). This effect corre-
lated with NQO2 activity. 10 mM K3 led to 3- to 4-fold activa-
tion of NQO2 at 1 and 6 h, respectively, while PQ stimulated
Figure 3. Reduction in the number of LC3 dots by PQ is not due to accelerated autophagic ﬂux. (A)
U373 cells were treated or untreated with 100 mM PQ for 24 h and with or w/o chloroquine (CQ,
25 mM) for 4 h before ﬁxation with paraformaldehyde. A representative confocal image (extended
focus of 5-mm deep stack) for each treatment and staining is shown. Bar: 25 mm. (B) Mean number
of LC3 vesicles per cell C/¡ SEM, calculated on n D 6 images per treatment, from 3 independent
experiments described in (A). Statistical analysis was performed by Mann-Whitney test, n D 6,
*P < 0.05, **P < 0.01. (C) WB analysis of LC3-II and SQSTM1 in U373 cells treated as in (A) and
exposed to 10 and 100 uM PQ, C/¡ CQ (25 mM) added 6 h before lysis. (D) PQ blocks rapamycin-
induced autophagy in U373 cells. 5 mM rapamycin (Rap) C/¡ PQ was applied for 24 h. The autoph-
agy ﬂux was blocked by 25 mM CQ applied 3 h before lysis and LC3 levels were analyzed in CQ-
treated and untreated cells.
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2-fold NQO2 activation within 20 h (Fig. 8D). Next, we
addressed the role of NQO2 in autophagy by genetic modulation
of its expression. NQO2 was silenced by transient transfection of
different NQO2-specific siRNAs or overexpressed by a stable
expression of the human NQO2-coding lentiviral construct
(Fig. 8E). NQO2 knockdown prevented PQ-induced reduction
in LC3 lipidation and partially reduced PQ-dependent accumu-
lation of SQSTM1 (Fig. 8F and G). In addition, NQO2 silenc-
ing markedly reduced the LC3 response to NMDPEF alone, but
augmented the response to NMDPEF in the PQ-treated cells
(Fig. 8F and G). We further analyzed LC3 processing in U373
cells stably overexpressing NQO2. NQO2 overexpression repro-
ducibly led to a stronger reduction of LC3 lipidation than in
control vector-expressing cells in response to PQ (Fig. 8H
and I). Strikingly, this correlated with a significantly higher sensi-
tivity of NQO2-transfected cells to PQ-induced toxicity, since
these cells massively underwent cell death 48 h after the treat-
ment with PQ in contrast to control vector-transfected cells,
which were still alive at this time point (Fig. 8J). The increased
mortality was mediated by an increased NQO2 activity in
NQO2-overexpressing U373 cells, since its inhibition by the
NQO2 inhibitor NMDPEF efficiently protected these cells
against cell death. In addition, cotreatment with the autophagy
inhibitor 3-methyladenine and PQ increased the percentage of
dead cells in NQO2-overexpressing and in control cells (Fig. 8J).
Thus, the residual autophagy in PQ-treated cells has a protective
function in astroglial cells, and its stimulation with the NQO2
inhibitor protects from PQ-induced cell death.
PQ and NMDPF cotreatment, but not PQ alone, stimulates
NFE2L2 activity independently from SQSTM1
Finally, we asked whether NFE2L2 was involved in PQ-depen-
dent inhibition of autophagy. NFE2L2 is a ubiquitously expressed
transcription factor that regulates the expression of genes bearing an
antioxidant response element (ARE) in the promoter region,
including NQO2.55 Importantly, autophagic activity inversely cor-
relates with NFE2L2-mediated antioxidant responses, due to
SQSTM1-dependent disruption of KEAP1-NFE2L2 binding on
Figure 4. Reduction of basal autophagy by long-term pretreatment with PQ leads to functional defects in antioxidant capacity of astrocytes. (A) U373
cells were cultured in the presence of 1 mM PQ for 7, 6, 4 and 2 d, under optimal culture conditions to prevent PQ-induced cell death. On d 7, CQ
(25 mM) was added 1 h before lysis. LC3 and SQSTM1 expression were analyzed by WB. (B) Densitometric analysis of data in (A); Mean C/¡ SEM; statisti-
cal analysis: one-way ANOVA followed by Dunnett’s post-test; n, number of analyzed experiments; 5 groups, 3 to 6 samples for each group, *P < 0.05,
**P < 0.01. (C) Representative confocal images (extended focus) of SQSTM1 immunostaining in control and PQ-long-term pretreated (LT-PQ) U373 cells
(7 days treatment with 1 mM PQ). Bar: 100 mm. Note accumulation of SQSTM1 aggregates in LT-PQ cells. (D–F) LT-PQ U373 cells are more sensitive to
H2O2 and less effectively protect dopaminergic SH-SY5Y neuroblastoma cells from H2O2-induced cell death. (D) Control (C), PQ-long-term pretreated
U373 cells (LT-PQ) and SH-SY5Y (SH) cells were plated separately under standard culture conditions and 2 days later exposed to 100 mM H2O2 for the
next 24 h. Cell mortality was analyzed by trypan blue exclusion assay and ﬂow cytometry. The graph shows the meanC/¡ SD of a representative experi-
ment out of 3 independent experiments, performed in triplicate. Statistical analysis: Mann-Whitney test, nD 3 in each group,#P< 0.05,##P< 0.01 indicate
signiﬁcant differences vs H2O2-treated C cells. (E) Control and LT-PQ U373 cells were mixed 1:1 with dopaminergic SH-SY5Y cells, plated on cover slips
and cultured for 2 d under standard conditions. Next, cocultures were exposed to 100 mM H2O2 for 24 h and subsequently ﬁxed and stained for GFAP
and DAPI. The ratio of SH-SY5Y dopaminergic cells to astroglial cells was assessed by counting GFAP-negative and GFAP-positive cells from at least 1000
DAPI-positive cells. The graph shows the mean ratio of GFAP¡ to GFAPC cellsC/¡ SEM, from 3 independent experiments, performed in triplicate. Statisti-
cal analysis: Mann-Whitney test, n D 9 samples in each group, **P < 0.01. (F) Representative confocal images (extended focus) of U373-SH-SY5Y cocul-
tures described in (E). Bar: 100 mm.
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Figure 5. Inhibition of autophagy in astroglial U373 cells and in primary astrocytes by PQ is mediated by oxidative stress. (A) ROS induction by PQ and
H2O2 as detected by CA-DCF-DA in U373 cells. Live ﬂuorescence of cell monolayers was analyzed by ﬂuorometry 1 h after staining with CA-DCF-DA. (B)
Mitochondrial ROS induction by PQ and H2O2 as detected by MitoSox staining and ﬂow cytometry in U373 cells. Statistical analysis for (A) and (B): one-
way ANOVA followed by Dunnett’s post-test, n D 6 samples for each CA-DCF-DA group, 6 groups; n D 4 ¡5 samples for each MitoSox group, 4 groups;
*P < 0.05, **P < 0.01. (C) H2O2 inhibits basal autophagy in U373 cells. The cells were treated with H2O2 (0.2 or 1 mM) for the indicated times, C/¡ CQ
(50 mM, added 1 h before the lysis). LC3 and SQSTM1 expression was analyzed by WB after 15% and 8% SDS-PAGE, respectively. (D) Densitometric analy-
sis of LC3-II (CCQ) and SQSTM1 bands (no CQ) from (C). Mean C/¡ SEM from 3 independent experiments. Statistical analysis: 2-way ANOVA followed by
Bonferroni post-test, time vs concentration, n D 3 samples for each group, 5 groups for each OD analysis; *P < 0.05, **P < 0.01, compared to vehicle-
treated cells. (E) Inhibition of autophagy in primary astrocytes in response to prolonged oxidative stress. Primary cultures of astrocytes isolated from
mouse cortex were treated or untreated with PQ (100 mM) or H2O2 (1 mM) C/¡ CQ (50 mM, 3 h before lysis) and analyzed for markers of autophagy as
described in (C). (F) 48 h before the treatment described in (E) the astrocytes were transfected with GFP-LC3 construct and analyzed for the presence of
green dots. Representative, extended focus confocal images of GFP-LC3-expressing cells, pretreated for 3 h with CQ (50 mM), are shown. Bar: 10 mm. (G)
Upregulation of SQSTM1 aggregates in primary mouse astrocytes exposed to prolonged treatment with PQ. Eight d after isolation primary cells were split
and then cultured in the presence (LT-PQ) or absence (Control) of 3 mM PQ for 7 d. Primary cultures were then stained for GFAP and SQSTM1 and ana-
lyzed by confocal microscopy. Bar: 20 mM.
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Figure 6. PQ activates pro-autophagic signaling pathways in spite of its negative effect on LC3 lipidation. (A) Samples from experiments described in
Fig. 1 (6 and 24 h PQ treatment) were analyzed for BECN1 expression by 8% SDS-PAGE and WB. Densitometric analysis of data (in lower panel) was per-
formed as described in Fig. 1B (TUBA/a-tubulin was used as loading control). (B) PQ causes accumulation of insoluble BECN1 in cells exposed for 48 h to
PQ. Samples of insoluble proteins in lysates were prepared and analyzed as described in Figure 1C. Statistical analysis for (A) and (B): one-way ANOVA
followed by Dunnett’s post-test; n indicates number of independent experiments; 4 groups, 3 – 6 OD values for each group; *P < 0.05, ***P < 0.001. (C)
U373 cells were seeded on coverslips and treated or untreated with 100 mM PQ for 6 h, ﬁxed and stained for BECN1 (green) and PIK3C3 (red). Represen-
tative confocal images of middle sections of stained cells are shown. Bar: 25 mm. (D–G) U373 cells were treated for the indicated time with 100 mM PQ
and cell lysates were analyzed by NuPage 4–12% gradient gel electrophoresis followed by WB. MTOR (D), RPS6KB/p70S6 kinase) (E), MAPK8 (F) and
MAPK1/3 (p44/p42) (G) phosphorylation were detected by phospho-speciﬁc antibodies. Densitometric analysis of n D 3 to 5 independent experiments
was performed. Statistical analysis: one-way ANOVA for (D and E; 7 groups each experiment) and Mann-Whitney test for (F and G; 5 – 9 OD values for
each control group, 3 - 5 OD values for other groups); *P < 0.05. (H) UO126 MEK1 inhibitor (0.2 mM) has little effect on basal autophagy and does not
restore autophagy in PQ-treated cells. (I) Effects of UO126 used in (I) on MAPK1/3 phosphorylation in U373 cells.
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the one hand56,57 and due to NFE2L2-dependent upregulation of
SQSTM1 on the other.58,59 First, we assessed the expression at pro-
tein level of NFE2L2,NQO2, and SQSTM1 inU373 cells exposed
to PQ, NMDPF, or PQCNMDPF for up to 24 h (Fig. 9A). PQ
induced the accumulation of SQSTM1 at 24 h, as expected, but
did not alter NFE2L2 levels. Though not statistically significant,
a transient upregulation of NQO2 protein level was observed in
PQ-treated cells. NMDPF alone
had no effects on the expression
of these 3 proteins. However,
when the cells were cotreated
with PQ and NMDPF, NFE2L2
levels significantly increased at
24 h (Fig. 9A). Next, NFE2L2
transcriptional activity was deter-
mined by luciferase reporter assay
monitoring ARE induction in
control, PQ, NMDPEF, and
PQCNMDPEF treatment con-
ditions. The cotreatment with
PQ and NMDPEF robustly
induced ARE-dependent tran-
scription (Fig. 9B), which is con-
sistent with the upregulation of
NFE2L2 under these conditions
(Fig. 9A). Finally, we asked
whether SQSTM1 could be
involved in NFE2L2 expression
and activity. To this end, we
repeated the experiments in
siRNA-SQSTM1-silenced cells.
Data shown in Figs 9C and D
confirm that PQ alone does
not induce NFE2L2 and also
demonstrate that transcrip-
tional activation of NFE2L2
(as probed by luciferase activ-
ity) in PQCNMDPF-treated
cells occurred independently
from SQSTM1.
Discussion
The data presented in this
paper led to several original and
rather unexpected conclusions.
We showed for the first time
that prolonged OS reduces the
basal autophagy rate in primary
astrocytes and U373 astrocy-
toma cells exposed to PQ or
H2O2, as evidenced by decreased
LC3 lipidation correlating with
impaired autophagosome for-
mation and concomitant accu-
mulation of SQSTM1 aggregates. Paradoxically, this occurs in
spite of an apparent activation of the majority of pro-autophagic
pathways by PQ. This inhibitory effect on autophagy is medi-
ated by the quinone reductase NQO2 and can be prevented by
pharmacological and genetic modulation of its activity. Pro-
longed inhibition of basal autophagy by low-doses of PQ has
functional consequences on the antioxidant capacity of
Figure 7. For ﬁgure legend, see page 1072.
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astrocytes and negatively affects their neuroprotective capability
toward dopaminergic cells exposed to OS.
These findings are unexpected for several reasons. First,
numerous previous reports documented the causal role of OS
induced by H2O2 in the activation of autophagy in different cell
systems,39,48,49,60,61 implicating O2
¡ as the main messenger of
this response. Second, in neuroblastoma cell lines62,63 and in
Drosophila synapse development64 OS induced by PQ was
reported to induce autophagy. Third, MPPT/MPPC, which is
structurally related to PQ, excessively stimulates an autophagic
response, leading to cell death in different neuronal cells.41,50,54
This led to the concept that nigrostriatal degeneration induced
by these toxins arises from a pathological enhancement of
autophagy in dopaminergic neurons. Furthermore, OS has been
implicated in the induction of autophagy under different experi-
mental conditions in vitro and in vivo, such as amino acid starva-
tion in cancer cell lines65 or ischemia/reperfusion in
cardiomyocytes.66 Finally, thiol antioxidants such as NAC or
vitamin E inhibit basal and rapamycin-induced autophagy.67
Accordingly, we also observed such a negative effect of NAC in
our system (Fig. 7B). In contrast, the specific NQO2 inhibitor
NMDPEF, that apparently shows a similar antioxidant activity,
elicited an increase of the autophagic activity in response to OS
(Fig. 7). This discrepancy suggests that the effect of an antioxi-
dant on cell physiology depends on its target(s) and its way of
action. Similarly, the source, type and time of action of OS may
have opposite effects on the autophagy machinery, as also
emerges from some recent findings and from more careful analy-
sis of the literature data.17 ROS generated in response to different
stimuli seem to both induce and inhibit upstream signaling path-
ways regulating autophagy and may also negatively influence
lysosomal function.54,68,69 For example, it has been reported that
rotenone inhibits autophagic flux via inhibition of lysosomal deg-
radation, as substantiated by increased levels of SQSTM1 and
SNCA in dopaminergic SH-SY5Y cells.70 The suppression of
autophagic flux was also observed in hepatoma cells in response
to H2O2 and TNF/TNFa
71 and in PRNP (prion protein)-defi-
cient hippocampal primary neurons, but not in normal hippo-
campal neurons exposed to H2O2, suggesting a possible role of a
functional PRNP in regulation of the autophagic response to
OS.72
In our experimental conditions, PQ-induced OS exerted a
dual effect on the autophagy machinery: on the one hand, it acti-
vated autophagy-inducing signals including MAPK1/3 and
MAPK8 pathways, inhibited MTOR and upregulated BECN1
(Fig. 6) and, on the other hand, it impaired LC3 processing, AV
formation (Figs. 1–3) and led to a reduced number of autolyso-
somes (Fig. 7C and E). The negative regulation of basal autoph-
agy by PQ (as well as by H2O2) was time- and dose-dependent.
The effect was hardly detectable after short exposure or with low
concentration (1 mM) of PQ (Fig. 1A). However, the prolonged
exposure to low concentrations or the acute exposure to higher
doses of PQ invariably led to the impairment of basal autophagy.
At low concentrations of PQ positive and negative signals are
balanced and no detectable response in terms of autophagy
induction is observed, in spite of a toxic accumulation of oxida-
tion products. In the long run, such a situation potentially leads
to astroglial degeneration. Indeed, astroglial cells survived up to
Figure 7 (See previous page). Pharmacological inhibition of oxidative stress by the speciﬁc NQO2 inhibitor NMDPEF, but not by N-acetylcysteine,
restores autophagy in PQ-treated astroglial cells. (A) NMDPEF abrogates PQ-induced oxidative stress detected by MitoSOX in a similar fashion to 5 mM
NAC. U373 cells were treated for 4, 8, 16, and 24 h with 100 mM PQ C/¡ NMDPEF (5 or 10 mM) or NAC (1 or 5 mM), incubated with MitoSox, detached
by trypsin and analyzed by ﬂow cytometry. The graph shows mean ﬂuorescence intensity (MFI) C/¡ SEM normalized to control (vehicle-treated) cells,
MFI D 1, from 3 independent experiments performed in triplicate. A polynomial curve was ﬁtted for each set of data. Statistical analysis: 2-way ANOVA
followed by Bonferroni post-test (6 treatments vs 4 time points), nD 3 in each time point and treatment; *P< 0.05, ***P < 0.001 when compared to con-
trol cells; x#P < 0.05, x##P < 0.01, x###P < 0.001 when x-treatment group is compared to PQ-treated cells. (B) NMDPEF, but not NAC, upregulates LC3 lipi-
dation and prevents its inhibition by PQ. U373 cells were treated or untreated with 100 mM PQ for 24 h, C/¡ NMDPEF (5 or 10 mM) or NAC (1 or 5 mM).
Two h before lysis the cells were treated with CQ (25 mM). LC3 and SQSTM1 expression were analyzed by 15% and 8% SDS-PAGE followed by WB, and
GAPDH and TUBA/a-tubulin were used as loading controls, respectively. (C) U373 cells were treated or untreated with 100 mM PQ for 24 h C/¡ NMDPEF
(10 mM), ﬁxed and stained for LC3 (red) and LAMP1 (blue). Representative confocal images (middle sections) are shown for each treatment. (D) Mean
number of LC3 dots per cell C/¡ SEM calculated as mean value per image on n D 9 images (each 4–8 cells) from 3 independent experiments described
in (C). Statistical analysis: one-way ANOVA followed by Bonferroni post-test, 4 groups, n D 9 images for each group; *P < 0.05, #P < 0.05. (E) Percentage
of LC3 dots colocalizing with LAMP1 was calculated as described in (D); the number of LC3 dots colocalizing with LAMP1 was counted on each image.
Statistical analysis as described in (D); ##P < 0.01. Note that NMDPEF restores autophagy by increasing the number of AVs and LAMP1-positive AVs. (F)
Treatment with PQ and NAC decreases, while NMPDEF increases, the number of acidic vesicles in PQ-treated and control cells. U373 cells were treated
with the indicated concentrations of NMDPEF and NACC/¡ PQ (100 mM) for 24 h, then trypsinized, stained with acridine orange (AO) and promptly ana-
lyzed by ﬂow cytometry. The ratio between mean far red (FL3) and green (FL1) ﬂuorescence intensity MFI (FL3/FL1) was determined on the entire viable
cell population. Mean C/¡ SEM of a representative experiment performed in quadruplicate out of 3 independent experiments with comparable results.
Statistical analysis: Mann-Whitney test, n D 4 samples in each group; *P < 0.05, when compared to vehicle-treated cells, #P < 0.05, when compared to
PQ-treated cells. (G-I) Protective effect of the NQO2 inhibitor NMDPEF against PQ in primary mouse astrocytes. Primary cultures were treated with PQ
C/¡ NMDPEF (10 mM) for the indicated times and analyzed for autophagy (G, H) and mortality (I) on day 12 and 14, respectively, after isolation from
mouse cortex. (G) WB analysis of LC3 levels. (H) Densitometric analysis of LC3-II/GAPDH ratio in WB from 3 independent experiments described in (G).
Statistical analysis: 2-way ANOVA followed by Bonferroni post-test, 3 treatments vs 2 times, n D 3 for each time point and treatment; **P < 0.01, when
compared to control cells; ##P< 0.01, PQ vs PQC NMDPEF. (I) Flow cytometry analysis of trypan blue-positive cells in primary cultures after trypsin-medi-
ated detachment. Mean § SD of a representative experiment performed in triplicate. Statistical analysis: one-way ANOVA followed by Bonferroni post-
test, 10 groups, n D 3 samples in each group; **P < 0.001, compared to vehicle-treated cells; ##P < 0.001, compared to the respective PQ-alone treated
cells. Note that NMDPEF restores basal autophagy in primary astrocytes exposed to PQ for 16 and 48 h and it correlates with signiﬁcant cell protection
on day 4.
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7 d under nonlethal concentrations of PQ (1 mM), but eventu-
ally showed a significant reduction in LC3-II levels associated
with a significant accumulation of insoluble SQSTM1 aggregates
(Fig. 4A–C), with a concurrent reduced resistance to OS and
neuroprotective capacity toward dopaminergic cells (Fig. 4D–F).
This observation can explain why PQ chronically administered
to rodents causes accumulation of protein inclusions, similar to
Lewy bodies in SN and other brain regions, before any loss of
dopaminergic neurons becomes apparent.73 Accordingly, a recent
report addressing the autophagic response to PQ in vivo reported
appreciable modulation of autophagic markers in different
regions of the brain, suggesting a possible inhibition of
Figure 8. For ﬁgure legend, see page 1074.
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autophagy in vivo by PQ, but not by maneb, another herbicide
implicated in PD etiology.30 However, the interpretation of the
results obtained in rodent models is hampered by the difficulty
in assessing the rate of autophagic flux in vivo.
Our in vitro system made it possible to show for the first time
an inhibitory effect of PQ on the autophagy machinery in astro-
cytes. In addition, we could demonstrate that such a negative
effect is mediated by the oxidoreductase NQO2. Several data
support this conclusion: (i) pharmacological inhibition of
NQO2 by NMDPEF potently upregulates LC3-II levels and
autophagosome formation, as well as autophagosome-lysosome
fusion and cell survival in the presence of PQ; (ii) NQO2 activa-
tion by menadione in astroglial cells leads to a rapid decrease in
LC3-II levels; (iii) silencing of NQO2 expression by siRNA or
shRNA reduces, whereas NQO2 overexpression (iv) augments,
the inhibitory effect of PQ on LC3 processing. Induction of
NQO2 activity and SQSTM1 accumulation by PQ did not cor-
relate with NFE2L2 activation. Intriguingly, in PQ-NMDPEF
cotreated cells NFE2L2 expression and activity were upregulated.
Astrocytes have been reported to possess high basal expression of
NFE2L2,13 and apparently PQ cannot further induce its expres-
sion, unless NQO2 is inhibited. This complex regulation defi-
nitely deserves a more in depth investigation. However,
considering the lack of correlation between NFE2L2 and
SQSTM1 levels (Fig. 9A) and no effect of SQSTM1 silencing on
NFE2L2 activity and levels (Fig. 9C and D), we can conclude
that PQCNMDPEF-induced NFE2L2 upregulation is
SQSTM1 independent in U373 astroglial cells.
Another interesting finding presented here is that primary
astrocytes and astroglial cell lines express much higher NQO2
protein levels compared to other brain cells (Fig. 8B). Consis-
tently, we found that PQ exerted its inhibitory effect on autoph-
agy mainly in astrocytes and to a lesser extent in other cell types
(Janda et al., unpublished observations).
We have recently demonstrated that NQO2 clearly contributes
to OS induced by PQ36 likely because its catalytic activity is intrin-
sically linked to ROS generation.74 Here, we confirm these findings
and show that overexpression of NQO2 further sensitizes astroglial
cells to PQ-induced cell death (Fig. 8J), an effect associated with
impairment of autophagy. Most importantly, we show that
NQO2-mediated inhibition of autophagy in astroglial cells has
pathophysiological consequences since it limits the intrinsic ability
of these cells to protect dopaminergic cells fromOS.
The mechanism involved in free radical production by NQO2
is unknown and difficult to envisage in consideration of the fact
that NQO2 catalyzes 2-electron reductions thought to be free of
ROS byproducts.37 In addition, the toxifying effects of NQO2
activity are difficult to reconcile with a proposed detoxifying
function of NQO2 in oxidative dopamine metabolism.75 Never-
theless, since NQO2 causes toxic activation of certain substrates
(menadione, mitomycin)37 and contributes to ROS production by
PQ,36 it cannot be excluded that similar ROS generating events
accompany dopamine quinone reactions mediated by NQO2.
Thus, under certain conditions, NQO2 can lead to chronic
OS and autophagy impairment, which may be prevented by
pharmacological inhibition of its activity. The upregulation of
basal autophagy associated with the inhibition of NQO2 activity
in the absence of exogenous OS (Fig. 8A) suggests that ROS-
independent mechanisms are also involved. The exact molecular
mechanism of NQO2-mediated inhibition of basal autophagy is
presently under investigation. Based on the differential effects
exerted by the antioxidants NAC (more general) and NMDPEF
(specific to NQO2-related ROS), we envisage a role for the local-
ized NQO2-dependent production of O2
¡, which might in
turn affect the machinery for LC3 processing.
Regardless of the molecular mechanisms implicated in
NQO2-dependent regulation of autophagy, the identification
of this novel regulator of autophagy in oxidatively stressed
Figure 8 (See previous page). Pharmacological and genetic manipulation of NQO2 effects on PQ-induced inhibition of autophagy. (A) Time- and dose-
dependent induction of autophagy by NMDPEF in U373 cells. LC3 and BECN1 expression were analyzed by WB by 15% and 8% SDS-PAGE, respectively.
(B) NQO2 expression is relatively high in murine primary astrocytes (A20, 20 mg total lysate) and U373 cells (U10, 10 mg total lysate) compared to the
total brain tissue (B10, 10 mg; B20, 20 mg total lysates). Anti-NQO2 rabbit Ab detects a single NQO2 band at 24–25 kDa (arrow) and nonspeciﬁc bands
with distinct electrophoretic mobility depending on the cell type or tissue (@). (C) Stimulation of NQO2 activity causes a rapid decrease in basal LC3-II lev-
els. U373 cells were treated with menadione (K3, 10 mM) for the indicated times C/¡ CQ (1 h, 50 mM) and LC3-II levels were assessed by WB. (D) NQO2
activity was measured in cells treated as described in (C) by ﬂuorometry of cosubstrate BNAH. K3 was added to living cells and the in vitro activity assay
was performed on total cell lysates. Mean C/¡ SEM of 3 independent experiments. Statistical analysis: one-way ANOVA followed by Dunnett’s post-test,
8 groups, nD 3 mean values in each group; *P< 0.05, **P< 0.01. (E, F) U373 were transected with control, no-target siRNA or 2 different siRNA targeting
human NQO2. 24 h later, PQ (100 mM) and/or NMDPEF (10 mM) or vehicle (DMSO) were added. 22 h later the cells were treatedC/¡ CQ (25 mM) for 2 h,
lysed and analyzed by WB for NQO2 expression and compared to NQO2-overexpressing cells (CNQO2) (E) and for markers of autophagy (F). (G) OD anal-
ysis of 3 independent experiments with NQO2 silencing as shown in (F). LC3-II/GAPDH OD ratio values are normalized to control siRNA-treated cells
(which were set to OD D 1). Statistical analysis was performed with one way ANOVA and Bonferroni post-test, 8 groups, n D 3 OD values per group, 6
OD values for the control group; *P < 0.05, ***P < 0.001, when compared to vehicle-treated control siRNA cells; $$P < 0.01, when compared to the
respective PQ-untreated cells; ##P < 0.01. (H) Overexpression of NQO2 sensitizes U373 cells to PQ-induced decrease of LC3-II levels. The autophagy ﬂux
was blocked by 25 mM CQ applied 4h before lysis. (I) OD analysis of 4 independent experiments with NQO2-overexpressing cells as shown in (H). LC3-II/
GAPDH OD ratio values are normalized to empty vector controls (OD D 1). Statistical analysis: Mann-Whitney test, n D 4 OD values for each group, 8 OD
values for the control group; *P < 0.05, when compared to empty vector cells; $P < 0.05, when compared to the respective PQ-untreated cells; #P < 0.05.
(J) Overexpression of NQO2 strongly sensitizes U373 cells to PQ-induced cell death and to the inhibition of autophagy by 3-methyladenine (3MA).
NQO2-overexpressing U373 cells and control (empty) vector-expressing cells were seeded under standard conditions. On the next day they were treated
C/¡ 100 mM PQ for 48 h. 3MA (5 mM) and NMDPEF (10 mM) were added for the last 8 and 48 h of the PQ treatment, respectively. Cell death was
assessed in triplicate by ﬂow cytometry of trypan blue pre-treated cells. Mean of 3 independent experiments C/¡ SEM. Statistical analysis: one-way
ANOVA followed by Bonferroni post-test, 10 groups, n D 3 mean values in each group; ***P < 0.001; ##P < 0.01, ###P < 0.001, when compared to PQ
alone-treated NQO2 cells; $$P< 0.01, when compared to PQ-treated empty vector cells.
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cells has important practical implications. NQO2 can be eas-
ily modulated pharmacologically by several natural and syn-
thetic inhibitors, including NMDPEF and certain flavonoids
such as quercetin and resveratrol. These findings will foster
future studies to define if pharmacological targeting of
NQO2 in vivo can prevent SQSTM1-positive protein inclu-
sions and pathological changes present in PD and other neu-
rodegenerative disorders.
Material and Methods
Cell culture
Astrocytoma U373 cells (kind gift of Michela Pollicita, Uni-
versity Tor Vergata, Rome, Italy) were cultured as previously
described.10 After thawing, cells were expanded in DMEM 4.5%
glucose (LONZA, 12-604) and then routinely cultured in stan-
dard medium: DMEM 1% glucose (LONZA, 12-707),
Figure 9. PQ and NMDPF cotreatment, but not PQ alone, stimulate NFE2L2 activity independently from SQSTM1. (A) WB analysis of NFE2L2, SQSTM1 and
NQO2 protein levels treated with PQ (100 mM), NMDPEF (5 mM) or PQ (100 mM) C NMDPEF (5 mM) for the indicated times. Graphs show the OD analysis
(ratio to GAPDH, normalized to vehicle-treated controls) as means C/¡ SEM of n D 3 blots from 3 independent experiments. Statistical analysis: one-way
ANOVA followed by Dunnett post-test; 5 groups, n D 3 - 6 OD values in each group; *P < 0.05, **P < 0.01. (B) NFE2L2 activity is activated by PQ plus
NMDPEF. U373 cells were transfected with ARE-Fireﬂy and Renilla luciferase reporter plasmids and 2 days later treated with 100 mM PQ or/and 5 mM
NMDPEF for 6 or 24 h. The ratio of Fireﬂy to Renilla luciferase activity was determined twice in triplicates. The graph shows meansC/¡ SEM of a represen-
tative experiment out of 3 independent experiments that yielded similar results. Statistical analysis: one-way ANOVA followed by Dunnett post-test; n D
6 determinations in each group, 5 groups; *P < 0.05, **P < 0.01. (C) U373 cells were transfected with a control siRNA or a SQSTM1-speciﬁc siRNA, treated
as indicated and analyzed by WB for the expression of SQSTM1, NFE2L2 and NQO2. GAPDH was used as loading control. (D) U373 cells were transfected
with reporter plasmids as described in (B) together with 1 mg of control siRNA or SQSTM1-targeting siRNA. The cells were then treated as indicated for
24 h and subsequently assayed for luciferase activity as described in (B). Statistical analysis: one-way ANOVA followed by Bonferroni post-test; *P < 0.05,
**P< 0.01, when compared to control cells; #P< 0.05, when compared to matched group expressing control siRNA. Note that NFE2L2-dependent lucifer-
ase activity is not suppressed by SQSTM1 silencing.
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supplemented with 2 mM L-glutamine (PAA Laboratories, M11-
004), 10% fetal calf serum, 1 mM sodium pyruvate (Gibco,
11360-070), 100 units/ml penicillin, 100 mg/ml streptomycin
(Pen/Strep, Gibco, 15070-063), in standard 5% CO2 conditions.
The medium was regularly changed every 48 h.
Isolation of primary astrocytes
Brains of 5 newborn pups (mouse strain Bl6/129, postnatal d
0–1) were isolated immediately after decapitation as previously
described.47 Briefly, the brains were placed on plastic dishes con-
taining sterile phosphate-buffered saline (PBS; Lonza, 4984) plus
Pen/Strep (1:100). Cortices were dissected, meninges carefully
removed and the tissue was cut into small pieces with scissors. All
the cortex tissue was then collected, resuspended in 10 ml of
DMEM, containing trypsin and DNAase (Sigma-Aldrich,
T4799, P4513) and digested for 30 min at 37C with occasional
shaking. The digested cortex was washed and plated on 5 culture
dishes (10 cm) in standard medium. The next day the medium
was changed and then renewed twice a wk. At confluence (usually
at d 7–9 after plating) the culture was washed 3 times with PBS,
trypsinized in 0.05% trypsin for 5–8 min and plated 1:3. When
confluent, the primary cells were split again and plated for
required experiments. All experiments were performed before
4 weeks after isolation. The percentage of astrocytes in primary
culture was assessed on the basis of GFAP positivity upon stain-
ing with rabbit anti-GFAP (Thermo Scientific, OPA-06100), fol-
lowed by anti-rabbit Alexa Cy5 (Molecular Probes, A-21070).
The animal care and procedure for sacrifice complied with the
recommendation of the local ethics committee.
Reagents and antibodies
Unless otherwise specified, all reagents were purchased from
Sigma-Aldrich: paraquat (M2254; 100 mM stock in PBS), chlo-
roquine (C6628; 25 mM stock in PBS), 3-methyladenine
(M9281; 10 mg/ml, 95% ethanol), DMSO (D4540), NAC
(A9165; 1 M stock in PBS), were kept in aliquots at ¡80C and
thawed shortly before each treatment. Rapamycin (37094) was
kept as 5 mM stock at ¡20C. H2O2 (95321) was diluted from
a 33% stock into 1 M aliquots and stored at ¡20C. NMDPEF
(a kind gift of Philipe Delagrange, Servier, France) was stored as
a 20 mM stock in DMSO at ¡20C.
The following antibodies (Abs) used for western blotting
(WB) were purchased from MBL International Corporation: rab-
bit anti-LC3 (PM036; used 1:4000 and occasionally 1:1000),
rabbit anti-BECN1 (PD017; 1:2000), anti-SQSTM1/p62,
mouse (M162-3; 1:1000) or rabbit (PM045; 1:2000). In some
experiments, the following Santa Cruz Biotechnology Abs were
used: rabbit anti-BECN1 (sc-11427; 1:200), goat anti-NQO2
(sc-18574; 1:200), rabbit anti-NFE2L2/NRF2 (sc-722, C-20;
1:1000), anti-TUBA/a-tubulin (sc-23948; 1:800) and rabbit
anti-GAPDH (clone FL335, sc-25778; 1:1000). Other Abs used
were from Sigma-Aldrich: rabbit anti-NQO2 (HPA332;
1:1000), anti-ACTB/b-actin (clone A40; 1:5000) and mouse
anti-GFAP (G4546; 1:1000). The following Abs were from Cell
Signaling Technology (used at 1:2000 or 1:1000), rabbit anti-
LC3B (used only for lysates from primary astrocytes; 2775),
anti-p-MTOR (Ser2448; 2971) and anti-MTOR (clone 7C10;
2983S), rabbit anti-p-RPS6KB/p70S6 kinase (Thr389; 9205S)
and anti-total RPS6KB/p70S6 kinase (2708S), anti-p-MAPK1/3
(P-p44/42, T202/Y204, clone 197G2, 4377S) and anti-
MAPK1/3 (p44/42, clone 3A7, 9107), anti-RPS6KB (p-SAPK/
JNK, T183/Y185, 4668). The Abs used for confocal immunoflu-
orescence analysis were: rabbit anti-PIK3C3/VPS34 (RayBio-
tech, RB-08-0037; 1:200), mouse anti-BECN1 (MBL, PM015;
1:100), mouse anti-LAMP1 (BD Biosciences, 611042; 1:100).
Secondary antibodies anti-rabbit (Alexa Fluor 568, A-11011 and
Alexa Fluor 488, A21206) and anti-mouse (Alexa Fluor 633, A-
21052) were used at 1:800 dilution and were purchased from
Molecular Probes. Fluorescein (FITC) phalloidin (Molecular
Probes, F432; 1:400) was used to detect actin.
Treatments and experimental setup for western blotting
analysis
U373 cells were seeded on plastic dishes 24 h before treat-
ment at the density 2 £ 104 cells/cm2 or 1 £ 104 cells/cm2 and
lysed 24 or 48 h after initial treatment, respectively. All treat-
ments were performed in freshly renewed medium and the com-
pound (PQ, NMDPEF, H2O2, NAC) was added for the
indicated time (usually 6, 24, 48 h) before the end of the experi-
ment, so that control and treated cells were all lysed at the same
time. CQ (25 mM or 50 mM) was added 1 to 6 h before the end
of the experiment, as specified; the time of exposure to CQ was
identical for each sample in the same experiment. For prolonged
incubation, U373 cells were seeded at low density (5 £ 104/cm2)
and cultured in 4.5% glucose DMEM for 7 d. A half volume of
the culture medium was renewed each day. Cells were exposed to
1 mM PQ for 7, 6, 4 and 2 d before the lysis and lysed at the
same time on day 7. CQ (25 mM) was added 1 h before lysis.
For signaling experiments the cells were treated for 15 and
30 min, and 1, 3, 6 and 24 h.
Western blotting
Cell monolayers were washed once with PBS and scraped in
cold Lysis buffer 1 (LB1) containing 50 mM Tris-HCl, pH 7.3,
150 mM NaCl and the following reagents from Sigma-Aldrich:
1% Igepal (I7771), 1 mM EDTA (E5134), 1 mM phenylme-
thylsulfonyl fluoride (P7626), phosphatase inhibitors (1mM
NaF [S1504], 0.01 mM sodium orthovanadate [S6508]) and
protease inhibitor cocktail (Complete Mini, Roche Diagnostic,
11836153001). The lysate was placed on ice for 10 min and
then centrifuged at 4C, 15000 g for 10 min. The supernatant
fraction was then mixed (3:1) with Laemmli Sample buffer (4 £:
100 mM Tris-HCl, pH 6.8, 4% SDS [Sigma-Aldrich, L4390],
16% glycerol, 20% 2-mercaptoethanol [Carlo Erba Reagents,
460691]), boiled 15 min at 90C and then stored at ¡80C
until analysis. Samples were boiled again for 3 min at 90C
before loading onto 15% or 8% polyacrylamide SDS (SDS-
PAGE) gels. Protein concentration was quantified by BCA pro-
tein assay (Thermo Scientific, 23227). Alternatively, for analysis
of detergent-resistant fractions of the lysates, cell monolayers
were lysed in LB1 as above. After centrifugation (4C, 15000 g
for 10 min), the pellets were washed once in 200 ml cold LB1
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buffer and then lysed in 30 ml Laemmli Sample buffer (4x) by
heating 10 min at 90C. Next LB1 buffer (30 ml) was added and
samples were heated again 10 min at 90C. For loading on gels,
it was assumed that protein concentration in the pellet fraction
was proportional to the protein concentration in the supernatant
fraction.
For analysis of serine-threonine phosphorylations (p-MTOR,
p-RPS6KB, p-MAPK1/3, p-MAPK8/JNK) cell monolayers were
washed in PBS containing NaF (1 mM) and lysed as described
previously.76 In general, 10–20 mg of protein lysate was loaded
on 15% or 8% SDS-PAGE gels or 4–12% Bis-Tris gradient
NuPAGE gels (Invitrogen, NP0323). For NQO2 expression
analysis, 50 mg of protein lysate was loaded on 10% gels. After
electrophoresis, polypeptides were electrophoretically transferred
to PVDF membranes (Bio-Rad, 162–0177), which were thereaf-
ter saturated with 5% milk (Panrea AppliChem, A0830) in
TTBS for 1 h at room temperature (RT). The primary antibody
was usually incubated overnight, followed by 2-h incubation
with secondary antibody. Blots were developed with the
enhanced chemiluminescence (ECL) procedure, using ECL
reagents (ImmunoStarTM, Bio-Rad, 170–5070 or Santa Cruz
Biotechnology, sc-2040) and digitally acquired using a Chemi-
Doc XRS imaging system (Bio-Rad Laboratories Inc., Hercules,
CA, USA).
Transient and lentiviral silencing of NQO2
Nonsilencing (control, All-stars, 1027280) siRNA and a set of
human NQO2-targeting siRNA were purchased from Qiagen
(1027416). Transfection of U373 cells was performed using
Lipofectamine 2000 (Life Technologies, Invitrogen, 11668027)
and Optimem (Invitrogen, 51985026) according to the man-
ufacturer’s instructions. Cells were incubated in Opitmem con-
taining siRNA-lipofectamine complexes for 6 h, washed with
DMEM and then incubated in culture medium containing
4.5% glucose for 20 h before treatments with PQ or NMDPEF
for 24 h. The nonsilencing siRNA was used as a negative control.
The silencing with lentiviruses coding for human NQO2-target-
ing shRNA was performed as previously described.36 Four d after
infection with lentiviral supernatant fractions U373 cells were
plated at standard conditions; 24 h later cells were treated with
PQ C/¡ NMDPEF for 24 h, lysed and assayed by WB for
autophagy markers and NQO2 expression. Sixty mg of total pro-
tein lysate were usually necessary to detect NQO2 with goat anti-
NQO2 (Santa Cruz Biotechnology) or less, if rabbit anti-NQO2
Ab (Sigma-Aldrich) was used.
Preparation of NQO2-overexpresing cells
NQO2-overexpressing U373 cells were generated by infection
with a lentivirus coding for human NQO2 pLenti6.2# £ 2044;
V5-DESTTM Gateway. This plasmid was obtained by clonase-
mediated recombination (Gateway LR Clonase Mix, Life Tech-
nologies, Invitrogen, 11791-020) between the destination vec-
tor and pENTRY221-NQO2 (clone ID IOH6580) according
to the manufacturer’s indications. Lentiviral particles were
generated in HEK293-FT cells (Invitrogen, R700-07) from
pLenti6.2#x2044;V5-DESTTM NQO2 plasmids and control
pLenti6.2/GW/emGFP (empty) vectors and used to infect U373
cells as described previously.36 After 6 d selection in blasticidin
(Invitrogen, R210-01) and 4 d recovery in the absence of the
drug, NQO2 overexpression was verified and NQO2-overexpress-
ing and control vector cells were used for experiments.
Immunofluorescence staining
For immunofluorescent staining, U373 cells were seeded (20–
30 £ 103 cells/cm2) on cover slips and the next day treated as
indicated, washed in PBS, fixed in 4% paraformaldehyde
(Sigma-Aldrich, 158127) in PBS (pH 7.4) for 5 min and then
blocked for 30 min at RT with PBS (pH 7.4) containing 1%
fetal bovine serum, 0.1% Tween 20 (Sigma-Aldrich, P-1379)
(blocking buffer). For immunodetection of antigens, the cells
were incubated for 1 h at RT with the primary antibody; after-
ward the coverslips were washed 3 £ in blocking buffer and then
incubated for 45 min with the secondary antibody. Antibody
dilutions were made in blocking buffer. After washing once in
blocking buffer and 2 times in PBS, the cover slips were finally
mounted on glass slides with 4 ml Slow-fade Gold mounting
reagent (Life Technologies, S36936). A negative control was per-
formed by omitting the primary antibody.
Confocal microscopy and analysis of images
Intracellular localization of LC3-positive vesicles, SQSTM1
dots and other markers of interest was assessed by confocal
microscopy. Images were collected on a Leica TCS sp5X confocal
microscope (LAS AF V2.2 DMI 6000 Argon Me Ne 543, Me
Ne 633) with a 40 £ ApoPLA oil immersion objective, magnifi-
cation 5 £, and 60 mm aperture (Leica Biosystems Inc., Buffalo
Grove, IL, USA). Z stacks of images were collected as described
previously.76 Extended focus projection were used to generate
the images used for counting of total number of LC3 vesicles and
SQSTM1 dots per cell. The colocalization analysis of LAMP1
and LC3 or SQSTM1 and LC3 was performed on a single cen-
tral plane confocal image showing 2 to 5 cells. Counting of dots
was performed manually and by ImageJ software. The parameters
for ImageJ analysis were adjusted suitably to obtain similar results
to manual counting. Several independent images with at least 50
cells were collected for each experiment. The mean of dots per
cell was first calculated for single image and then the mean for
the entire experiment was calculated by adding the single image
means divided by the total number of images.
Live imaging of GFP-LC3 positive vesicles
Primary mouse astrocytes (12 d after isolation) were plated at
the density 2 £ 104 £ cm¡2 on coverslips in 12-well plates and
the next day transfected with 0.75 mg of GFP-LC3 plasmid
(kind gift of Dr E. Bampton, Leichester, UK) per well with
1.5 ml Lipofectamine 2000 (Invitrogen, 11668027) according to
the manufacturer’s instructions. 48 h after transfection, cells
were treated as required and 24 h later live cell images were
recorded on an A1r Nikon inverted confocal microscope
equipped with resonant scanner for fast imaging and motorized
XY stage by using a 63X CFI Plan APO VC 1.4 DT:0.13mm
immersion oil objective (Nikon AG Egg/ZH, Switzerland). For
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confocal z-axis stacks, 25 images separated by 0.2 mm along the
z-axis were acquired.
Detection of acidic vesicles by flow cytometry
U373 cells were seeded and cultured on 24-well plates as for
WB experiments, but at the end of the 24-h treatment the cells
were incubated for 15 min with 10 mg/ml acridine orange
(Sigma-Aldrich, 318337). Next, the cells were washed once in
PBS, trypsinized for 3 min, collected with 1 ml 10% fetal calf
serum culture medium in conical tubes (for flow cytometry anal-
ysis), centrifuged at 800 g for 5 min and suspended in 0.4 ml
PBS containing 1% BSA (Santa Cruz Biotechnology, 9048-46-
8) and 0.1% EDTA (Sigma-Aldrich, E5134). Cells were acquired
in the far red (>650 nm, FL3) channel and in the green channel
(510–530 nm, FL1) by FACSCanto II (BD Biosciences, Eren-
bodgem, Belgium). Mean fluorescence intensity (MFI) for FL1
and FL3 channels was determined on the entire viable cell popu-
lation by BD FACSDiva software. The ratio of MFI (FL3)/MFI
(FL1) was calculated for each sample and data analyzed by
Microsoft Excel.
Mitochondrial ROS detection by MitoSox
To detect ROS in mitochondria U373 cells were treated or
untreated with PQ (200 mM) or H2O2 (200 mM) before analy-
sis. MitoSox (Molecular Probes, M36008) staining and flow
cytometry were performed as previously described.36
NQO2 activity assay
NQO2 acitivity in U373 cells was measured as previously
described36 with a few modifications. Briefly, U373 cells plated
and cultured under standard conditions were treated with
10 mM menadione (K3, Supelco, 4-7775; 10 mM stock in etha-
nol), or PQ and then homogenized on ice with a glass tissue
grinder (Wheaton, 357538) in reaction buffer (50 mM Tris-
HCl, pH 7.5, 1 mM n-octyl-b-D-glucopyranoside [Sigma-
Aldrich, O8001-100 MG]). 5 mg of freshly prepared cell homo-
genates were added to a reaction mixture containing 150 ml
of reaction buffer and 10 mM BNAH (Santa Cruz Biotech-
nology, 208609) and no K3. The decrease in BNAH fluores-
cence was monitored for 30 min at RT and normalized to a
spontaneous decay in BNAH fluorescence in the absence of
cell homogenate.
ROS detection by a DCF (dichlorofluorescein) derivative
U373 cells were plated at standard conditions (2 £ 104/cm2)
in 96-well plates. PQ (100 mM) or H2O2 (200 mM) was added
at 24, 6 or 3 h or 60, 30 and 15 min before analysis (all treat-
ments were performed 6 times). Cell staining with cytoplasmic
ROS fluorescent indicator 5(6)-carboxy-20,70 dichlorofluorescein
diacetate (CA-DCF-DA; Sigma-Aldrich, 21884) was performed
1.5 h before analysis. For this purpose, the conditioned medium
C/¡ PQ or H2O2 was temporarily removed from cells (kept in
the incubator in the meantime) and the cells were incubated with
prewarmed basal DMEM containing 20 mM CA-DCF-DA or
vehicle (DMSO) for 30 min. Stained cells were gently rinsed in
warm basal DMEM and incubated again for 1 h with
conditioned medium. Where indicated, PQ or H2O2 was added
for short-term treatments. Fluorescent signal detection of live cell
monolayers was performed on multilabel fluorimeter Victor 2
(Perkin-Elmer, Singapore) with fluorescein filter settings. Back-
ground readings (cells stained with DMSO) were subtracted for
analysis of fluorescence of DCF-stained cells.
Transfection of siRNA and cDNA and luciferase reporter
assay
Transfection of reporter plasmids and siRNA was performed
with Lipofectamine 2000 (Invitrogen, 11668027), which was
used according to the manufacturer’s instructions. SQSTM1
siRNA (EHU027651) and control siRNA (EHUEGFP) were
purchased from Sigma-Aldrich. Reporter assay plasmids (ARE–
firefly luciferase and thymidine kinase (TK)-Renilla luciferase
(internal control) were purchased as Cignal reporter kit (Qiagen,
CCS-5020L) and used according to the manufacturer’s instruc-
tions. In particular, 1.5 to 2 mg of reporter DNA and 1 mg of
siRNA per 35-mm plate were used for the transfection of subcon-
fluent U373 cells. Luciferase activities were measured by using
the Dual-Luciferase Reporter Assay system (Promega, E1910) in
96-well plates on a Multilabel luminometer/fluorimeter Victor 2
(Perkin-Elmer, Singapore). The experiment was run in triplicate
and each measurement was repeated 3 times.
Data analysis and statistical procedures
Statistical analysis of all the experiments was performed using
GraphPad Prism software (version 3.0). The data were pre-
sented as means §SEM (95% confidence interval) of 3 or more
independent experiments, unless otherwise specified. The statis-
tical significance of the differences between treatments was
evaluated by analysis of variance test ANOVA, one-way or
2-way depending on the number of variable parameters, fol-
lowed by Dunnett’s or Bonferroni multiple comparison tests,
respectively. Mann-Whitey or unpaired 2-tailed t test test were
used for 2 small-size (n < 10) or 2 middle-size (n  10) group
comparisons.
Optical density of western blots was assessed by Quantity
One image software (Bio-Rad) for each individual blot and
the respective loading control. The main OD values were
divided by loading control OD and normalized to OD values
in untreated cells. The latter were assigned an arbitrary value
of “1” or 100%. All experiments were replicated at least
3 times.
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